Health Assessment Study (0954-946)

• Status: Completed
• Trial end date: 2003-01-23
• Target enrollment: 0
• Participant gender: Male

Summary

The study will look at the effects of losartan or atenolol on frequency of sexual intercourse in subjects with newly diagnosed mild to moderate hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Atenolol

Criteria

Inclusion Criteria:

• Newly diagnosed with mild to moderate hypertension\

• Married male in stable heterosexual relationship

• No prior history of sexual dysfunction

• Satisfied with overall sex life

• Patient's spouse is in close proximity for the study

• Has had at least 2 but not more than 10 sexual intercourse events during the 2 week period prior to study start

• Patient able to visit doctor in the morning of each scheduled visit

• Able to complete the self administered health assessment questionnaire

Exclusion Criteria:

• Hypertension due to cancer, history of heart or circulatory problems

• History of mental disorder that might impair sexual function

• History or presence of drug or alcohol abuse

• Prior surgery for erectile dysfunction or other urological procedure

• No penile implant or assist devices

• History of chronic liver disease, history of diabetes

• History of severe life-threatening diseases such as, cancer, AIDS or positive HIV test

• Subjects with only 1 kidney

• Mental handicap or legal incapacity